Universal Biosensors, Inc.

Equities

UBI

AU000000UBI2

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 01:50:07 2024-04-26 am EDT			5-day change	1st Jan Change
0.15 ^AUD	-11.76%		-9.09%	-25.00%

Apr. 19	Universal Biosensors Opens AU$10 Million Rights Issue	MT
Apr. 11	Universal Biosensors to Raise AU$10 Million for Technology Development	MT

Universal Biosensors, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023

July 30, 2023 at 06:50 pm EDT

Universal Biosensors, Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was AUD 2.6 million compared to AUD 1.44 million a year ago. Net loss was AUD 2.39 million compared to AUD 17.62 million a year ago.

Latest news about Universal Biosensors, Inc.

Universal Biosensors Opens AU$10 Million Rights Issue	Apr. 19	MT
Universal Biosensors to Raise AU$10 Million for Technology Development	Apr. 10	MT
H&G High Conviction Reports Flat Performance for March Quarter	Apr. 10	MT
Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	Apr. 09
Australian Shares Rise as Central Bank Maintains Interest Rates	Mar. 19	MT
Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%	Mar. 18	MT
Transcript : Universal Biosensors, Inc., 2023 Earnings Call, Mar 07, 2024	Mar. 06
Universal Biosensors Narrows 2023 Loss on Absence of Impairment, Higher Revenue; Shares Down 6%	Feb. 29	MT
Universal Biosensors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Universal Biosensors Grows H2 2023 Sales by 55%	Jan. 31	MT
Transcript : Universal Biosensors, Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 01
Universal Biosensors, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-29	CI
Universal Biosensors' Coagulation Analysis Device Gets Approval in Europe	23-10-04	MT
Universal Biosensors Secures Marketing Approval, First Order for Coagulation Analyzer Device in India	23-08-31	MT
Universal Biosensors Secures First Major Tender to Supply Xprecia Prime in Italy	23-08-08	MT
Transcript : Universal Biosensors, Inc., Q2 2023 Earnings Call, Aug 08, 2023	23-08-07
Australian Shares Flat Ahead of Central Bank Policy Meeting	23-07-31	MT
Universal Biosensors Narrows Net Loss 74% in H1	23-07-30	MT
Universal Biosensors, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-30	CI
Universal Biosensors, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-30	CI
Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	23-05-21
Universal Biosensors Trims Q1 Loss on Lower Expenses, Absence of Intangible Assets Impairment	23-05-11	MT
Universal Biosensors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Universal Biosensors Launches Blood Glucose Monitoring Product for Dogs and Cats	23-05-03	MT
Universal Biosensors Introduces Sixth Product on Sentia Wine Testing Platform	23-04-19	MT

Chart Universal Biosensors, Inc.

Duration

Period

More charts

Company Profile

Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, womenâs health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
UNIVERSAL BIOSENSORS, INC.	-25.00%	22.64M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology